Search Results

The most reliable test for the detection of fetal syndromes starting at week 9 of pregnancy A NIPT test is a simple blood test, used to detect chromosomal syndromes in the fetus. Known and common syndromes, such as Down syndrome, can be identified by purifying the placental DNA. MaterniT Focus is the longest-standing and safest test that can evaluate exactly what is needed. The tests are performed at the US Labcorp laboratories, the world pioneer in NIPT testing. About Sent :) << Phone Email Name < Send Low price Focused on what's important Clear result Positive / Negative A simple blood test Numerous centers or a nurse at your door Fast result Result received within 5-10 days Professional and reliable Expert genetic counseling with 25 years experience Wholly effective Single pregnancies, twins, triplets, IVF... About us Pronto Diagnostics – a veteran company in the Israeli field of genetic diagnosis. Pronto is the exclusive marketer of the MaterniT Focus test - the most accurate test in Israel for the detection of genetic syndromes in the fetus, in the earliest week of pregnancy. Pronto has been active in the development, production, and marketing of genetic diagnostic kits since 1993 – building on many years of experience and uncompromising reliability. Pronto has operated a clinical genetic laboratory since 2009 - and provides an advanced molecular diagnosis service in the clinical and research fields. Pronto is an exclusive distributor in Israel of advanced products, technologies and laboratory services in the field of molecular genetics - and has exclusive collaborations with research bodies and international diagnostics companies. About We are here for you To provide you with the best test for your precious pregnancy

About the NIPT test NIPT, or Non-Invasive Prenatal Testing, is a non-invasive screening test used to detect additions and deletions in specific chromosomes that cause significant syndromes (Down syndrome, Edwards syndrome and Patau syndrome), as well as sex chromosome disorders. ​ The MaterniT Focus test was developed by Sequnom, the company we collaborate with, and is based on exclusive patents. The test was developed in order to avoid the need for invasive tests that can endanger the fetus as well as the mother. This was made possible thanks to the discovery of free DNA present in the blood of pregnant women that originates in the placenta; this discovery led researchers to develop, for the first time, a method for the analysis of free DNA - thus making it possible to identify mutations in the fetus. The reliability of this test has been proven time and again in millions of tests. The uniqueness of MaterniT Focus is that in order to perform it, only 2% of the free DNA in the mother's blood must be from a placental source, compared to 4% in competing tests. This figure means that our test will provide more reliable and definitive results compared to other tests, which will not be able to obtain a result, or whose results will not be unequivocal. In order to perform MaterniT Focus , only one blood test is required, instead of the two required for other tests, and the percentage of definitive results obtained is higher. ​ As of 2013, the NIPT test has been approved for clinical use in Israel by the Ministry of Health. According to the Ministry of Health website, "A blood test performed using maternal blood has a very high detection rate (about 99%), and it is possible that in the future, this test will replace screening tests for fetuses with Down syndrome as well as prenatal tests such as chorionic villus sampling or amniocentesis." More Info We are here for you To provide you with the best test for your precious pregnancy

We will be happy to hear from you With decades of experience in genetic diagnostics, Pronto Diagnostics is the pioneer of NIPT testing in Israel. We are here to answer your questions. Send an E-mail nipt@prontodiagnostics.com Please leave your details and we will get back to you soon E-mail Phone Name Message Thank you :) Send

​Basic Trisomies (an extra chromosome): Chromosome 21 - Down syndrome Chromosome 18 - Edward syndrome Chromosome 13 - Patau syndrome Fetal sex (the only test in Israel that identifies the sex of each fetus separately, in twin pregnancies) ​ Basic Plus Trisomies (an extra chromosome) Fetal sex Fetal sex chromosomes: X,45 - Turner syndrome XXY,47 - Klinefelter syndrome XXX,47 - Triple X syndrome XYY,47 - XYY syndrome What is reported by Benefits of Professional and Efficient - The only test suitable for multiple pregnancy Efficient in IVF twin pregnancies or surrogate pregnancies Identifies syndromes in one or both fetuses in twin pregnancies The only test that can identify and provide a result in the case of fetal resorption Dozens of centers at which the test can be performed, or by a nurse at your door Precise and Reliable - The highest percentage of definitive test results The highest rate of identification in women with a high BMI Only 0.9% of tests yield no results, as opposed to 3% among competitors Saves you Invaluable time - Can be performed starting at 9 weeks pregnant Results are received within 5 - 10 days (14 days at the most) Results are clear - Positive / Negative Genetic consultation with the experts at Labcorp Refunds from the HMOs and private insurance Who is the test recommended for For all women, starting at the 9th week of pregnancy. For multiple pregnancies. For high-risk pregnancies. For women who are not interested in undergoing amniocentesis. For pregnant women for whom it is important to know, at an early stage, whether the fetus has any of the common syndromes. For women for whom a sense of security during pregnancy is important. About Labcorp Genetics Sequnom, a pioneer in non-invasive pregnancy testing - NIPT, was founded in San Diego, California, in 1994. Sequnom has developed its molecular technologies and set up a state-of-the-art genetic laboratory to perform these tests. Sequnom was acquired by the international Labcorp company, the owner of the original patents for NIPT tests. To date, these laboratories have conducted the most extensive clinical trials in the field of NIPT, a fact that confirms that they are the most experienced and reliable laboratories in the world. We are here for you To provide you with the best test for your precious pregnancy

Search Results 5 items found for "" Blog | MaterniT FocusMaterniT Focus ראשי Search No posts published in this language yet Once posts are published, you’ll see them here. More Info | MaterniT FocusMaterniT Focus ​Basic Trisomies (an extra chromosome): Chromosome 21 - Down syndrome Chromosome 18 - Edward syndrome Chromosome 13 - Patau syndrome Fetal sex (the only test in Israel that identifies the sex of each fetus separately, in twin pregnancies) ​ Basic Plus Trisomies (an extra chromosome) Fetal sex Fetal sex chromosomes: X,45 - Turner syndrome XXY,47 - Klinefelter syndrome XXX,47 - Triple X syndrome XYY,47 - XYY syndrome What is reported by Benefits of Professional and Efficient - The only test suitable for multiple pregnancy Efficient in IVF twin pregnancies or surrogate pregnancies Identifies syndromes in one or both fetuses in twin pregnancies The only test that can identify and provide a result in the case of fetal resorption Dozens of centers at which the test can be performed, or by a nurse at your door Precise and Reliable - The highest percentage of definitive test results The highest rate of identification in women with a high BMI Only 0.9% of tests yield no results, as opposed to 3% among competitors Saves you Invaluable time - Can be performed starting at 9 weeks pregnant Results are received within 5 - 10 days (14 days at the most) Results are clear - Positive / Negative Genetic consultation with the experts at Labcorp Refunds from the HMOs and private insurance Who is the test recommended for For all women, starting at the 9th week of pregnancy. For multiple pregnancies. For high-risk pregnancies. For women who are not interested in undergoing amniocentesis. For pregnant women for whom it is important to know, at an early stage, whether the fetus has any of the common syndromes. For women for whom a sense of security during pregnancy is important. About Labcorp Genetics Sequnom, a pioneer in non-invasive pregnancy testing - NIPT, was founded in San Diego, California, in 1994. Sequnom has developed its molecular technologies and set up a state-of-the-art genetic laboratory to perform these tests. Sequnom was acquired by the international Labcorp company, the owner of the original patents for NIPT tests. To date, these laboratories have conducted the most extensive clinical trials in the field of NIPT, a fact that confirms that they are the most experienced and reliable laboratories in the world. We are here for you To provide you with the best test for your precious pregnancy Nipt | NIPT MaterniT Focus | Israel The most reliable test for the detection of fetal syndromes starting at week 9 of pregnancy A NIPT test is a simple blood test, used to detect chromosomal syndromes in the fetus. Known and common syndromes, such as Down syndrome, can be identified by purifying the placental DNA. MaterniT Focus is the longest-standing and safest test that can evaluate exactly what is needed. The tests are performed at the US Labcorp laboratories, the world pioneer in NIPT testing. About Sent :) << Phone Email Name < Send Low price Focused on what's important Clear result Positive / Negative A simple blood test Numerous centers or a nurse at your door Fast result Result received within 5-10 days Professional and reliable Expert genetic counseling with 25 years experience Wholly effective Single pregnancies, twins, triplets, IVF... About us Pronto Diagnostics – a veteran company in the Israeli field of genetic diagnosis. Pronto is the exclusive marketer of the MaterniT Focus test - the most accurate test in Israel for the detection of genetic syndromes in the fetus, in the earliest week of pregnancy. Pronto has been active in the development, production, and marketing of genetic diagnostic kits since 1993 – building on many years of experience and uncompromising reliability. Pronto has operated a clinical genetic laboratory since 2009 - and provides an advanced molecular diagnosis service in the clinical and research fields. Pronto is an exclusive distributor in Israel of advanced products, technologies and laboratory services in the field of molecular genetics - and has exclusive collaborations with research bodies and international diagnostics companies. About We are here for you To provide you with the best test for your precious pregnancy Contact Us About | MaterniT FocusMaterniT Focus About the NIPT test NIPT, or Non-Invasive Prenatal Testing, is a non-invasive screening test used to detect additions and deletions in specific chromosomes that cause significant syndromes (Down syndrome, Edwards syndrome and Patau syndrome), as well as sex chromosome disorders. ​ The MaterniT Focus test was developed by Sequnom, the company we collaborate with, and is based on exclusive patents. The test was developed in order to avoid the need for invasive tests that can endanger the fetus as well as the mother. This was made possible thanks to the discovery of free DNA present in the blood of pregnant women that originates in the placenta; this discovery led researchers to develop, for the first time, a method for the analysis of free DNA - thus making it possible to identify mutations in the fetus. The reliability of this test has been proven time and again in millions of tests. The uniqueness of MaterniT Focus is that in order to perform it, only 2% of the free DNA in the mother's blood must be from a placental source, compared to 4% in competing tests. This figure means that our test will provide more reliable and definitive results compared to other tests, which will not be able to obtain a result, or whose results will not be unequivocal. In order to perform MaterniT Focus , only one blood test is required, instead of the two required for other tests, and the percentage of definitive results obtained is higher. ​ As of 2013, the NIPT test has been approved for clinical use in Israel by the Ministry of Health. According to the Ministry of Health website, "A blood test performed using maternal blood has a very high detection rate (about 99%), and it is possible that in the future, this test will replace screening tests for fetuses with Down syndrome as well as prenatal tests such as chorionic villus sampling or amniocentesis." More Info We are here for you To provide you with the best test for your precious pregnancy Contact us Contact | MaterniT FocusMaterniT Focus We will be happy to hear from you With decades of experience in genetic diagnostics, Pronto Diagnostics is the pioneer of NIPT testing in Israel. We are here to answer your questions. Send an E-mail nipt@prontodiagnostics.com Please leave your details and we will get back to you soon E-mail Phone Name Message Thank you :) Send

ראשי Search No posts published in this language yet Once posts are published, you’ll see them here.